Tamico Produces 7 new pharmaceutical brands, Sells 7 billion in 3 months

The Arab Medical Company “Tamico” has announced the production of seven new medicinal classes that include anti acids, diarrheals, anti-inflammatories, antihypertensives, muscle relaxants and general body tonics.

The company is proceeding with two parallel production lines, which are the return of traditional items and the introduction of new products that are not on the company’s production list like antibiotics, which are azithromycin and clarithromycin that are in demand at the market.

Tamico has been proceeding since 2018 with an upward graph, where last year’s sales were 20 billion Syrian pounds with a production rate of 23 billion pounds. The company is expected to achieve 25 billion pounds of sales and 30 billion pounds of production this year, based on the figures of the first quarter of 2022, where the company has achieved 7 billion pounds of sales and 8 billion pounds of production.

As far as pricing is concerned, the rise in drug prices globally and the high exchange rate in addition to the high freight charges as a result of the higher costs of oil derivatives, have all contributed to the rise in drug costs.